Home › Products › Orthopaedics › Phostat 667mg Tablet
Phostat 667mg Tablet
Salt Composition: CALCIUM ACETATE
- Manufacturer: ZYDUS CADILA
- Pack Size: 10 TABLET(s) IN A STRIP
- Dosage Form: TABLET
- Strength: 667MG
- No Prescription Required
- Storage: Should be stored at room temperature, between 20°C to 25°C. Keep away from moisture, heat, and light. It should not be frozen. Keep away from children and pets.
₹31.00₹39.60
Inclusive of all taxes
Product Introduction
Phostat 667mg tablet contains calcium acetate. It is used to manage hyperphosphatemia, elevated phosphate levels in the blood. It is primarily indicated for patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) undergoing dialysis. It helps maintain bone health and reduce the risk of bone fractures and other bone-related complications. Phostat 667mg tablet may reduce the risk of cardiovascular problems such as heart disease and calcification of blood vessels. It can be used alongside dietary modifications to improve phosphate level control. High phosphate levels can contribute to itching and skin irritation, common symptoms in patients with kidney disease. Lowering phosphate levels with this medication may provide relief from these symptoms.
Avoid Phostat 667mg tablet if you have hypersensitivity or allergic reaction to calcium acetate or any component. Patients with severe kidney impairment or impairment of calcium metabolism should avoid this medication. Caution should be exercised in patients with a history of kidney stones or kidney disease and those taking medications containing calcium or magnesium. Use is generally not recommended in children due to insufficient clinical data in paediatric populations. In older individuals, this medication should be used with caution as they may have increased risk of impaired kidney function, cardiovascular issues, and calcium-related disorders. Consult a healthcare professional before starting this medication in older age.
Uses
Phostat 667mg tablet is used in the following: Hyperphosphatemia in CKD/ESRD Adjunct to dietary management in CKD/ESRD dialysis
How it works
Phostat 667mg tablet's therapeutic action is its ability to bind with dietary phosphate in the gastrointestinal tract. Upon ingestion, it dissociates into calcium and acetate ions. The calcium ions form insoluble complexes with phosphate ions from ingested foods, forming calcium phosphate salts that are not absorbed into the bloodstream. As a result, phosphate absorption from the diet is reduced, leading to lower phosphate levels in the blood.
How to Use
Phostat 667mg tablet is typically administered orally, meaning it is taken by mouth as tablets or capsules. The medication is designed to be swallowed with water and should not be chewed or crushed unless specifically instructed by a healthcare provider. The oral route is the most common and effective way to use this medication to manage hyperphosphatemia in individuals with chronic kidney and end-stage renal disease.
Side Effects
Phostat 667mg tablet causes some side effects like all medications, although not everyone will experience them. Serious: Hypercalcemia Calcium-based tissue deposition Aluminum toxicity Common: Upset stomach Constipation Abdominal pain Loss of appetite Itching Hypocalcemia
Expert Tips
Inform your healthcare provider about your complete medical history, allergies, and ongoing medications or supplements to ensure safe usage. Regular monitoring of blood phosphate levels is important to assess the effectiveness of the Phostat 667mg tablet in managing hyperphosphatemia. Stick to dietary recommendations your healthcare provider provides to complement the medication's effects. Be vigilant for symptoms of hypercalcemia, such as nausea, vomiting, and confusion, as well as symptoms of hypocalcemia. If you experience any adverse effects, consult your healthcare provider, who may adjust the dosage or recommend alternative treatments. Pregnant and breastfeeding individuals should seek guidance from a healthcare provider before using this medication. Discuss your allergies, history of hypersensitivity reactions, or underlying conditions like liver or lung issues with your healthcare provider before starting them. Always consult your healthcare provider for personalized advice and guidance on the safe and effective use of this medication in your specific circumstances.
References
- RenaCare NephroMed GmbH, Electronic Medicines Compendium (EMC), [Revised on Feb 2012] [Accessed on 22 August 2023], https://www.medicines.org.uk/emc/files/pil.4646.pdf
- Genzyme Ireland Ltd, US Food and Drug Administration, [Revised on: 04/2020 ] [Accessed on 23rd August 2023] , https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022127s019,022318s021lbl.pdf
- J. Goddard, A.N. Turner, Kidney and Urinary Tract Disease, Davidsonâs Principles and Practice of Medicine, 22nd Edition, 2014, 461-523.
Safety Advice
Pregnancy: Consult your doctor Pregnant women should consult their healthcare provider before taking Phostat 667mg tablet as its safety is not well studied in pregnant women.
Lungs: Consult your doctor If you have lung conditions, it is advisable to consult your healthcare provider before using Phostat 667mg tablet.
Breastfeeding: Consult your doctor Phostat 667mg tablet's safety during breastfeeding is not well established. Consult a healthcare provider before using this medication while breastfeeding.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.